RxDoctor Payments Data

Bryan Emmerson, MD

Orthopaedic Surgery · Santa Barbara, CANPI 1700033099

Payments from drug & device makers

What this record shows

This record is dominated by other: $195,351 of the $223,010 with a category attached, or 87.6%. Encore Medical, LP accounts for 88.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $203,689 and has fallen 99.6% since, to $878 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$223,010in general payments, 2019–2025

Across 39 payments — averaging $5718.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$196K
  • Orthalign Inc$11K
  • Insight Medical Systems, Inc.$9K
  • Medical Device Business Services, Inc.$5K
  • Johnson & Johnson$286
  • Naviswiss, Inc.$242
  • plus $453 from 5 others
$20,443in ownership & investment interests, 2019–2025

Across 6 payments — averaging $3407.17 each. An ownership or investment interest held by the physician or an immediate family member.

  • Orthalign Inc$20K

What the payments were for

  • Consulting fees$15,5107%
  • Speaking & faculty fees$7,8003%
  • Travel & lodging$2,7281%
  • Food & beverage$1,6211%
  • Other$195,35188%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$223,010 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$509,644
Medicare patients
853
Services billed
4,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen206$2,979
Celecoxib53$2,130
Naloxone Hcl29$2,048
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen196$1,938
Tramadol Hcl309$746
Cephalexin131$627
Meloxicam171$444
Ondansetron OdtOndansetron57$253
Dexamethasone37$168
Mupirocin16$118
Amoxicillin26$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Santa Barbara

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →